SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,830.68 724.03
( 0.89%)

Global Indices

Nasdaq

52,245.46 -165.29
(-0.32%)

Dow Jones

7,531.52 -39.42
(-0.52%)

Hang Seng

61,257.85 798.27
(1.32%)

Nikkei 225

10,782.38 -0.49
(0.00%)

Forex

USD-INR

93.78 -0.25
(-0.27%)

EUR-INR

104.91 0.16
(0.15%)

GBP-INR

125.72 0.20
(0.16%)

JPY-INR

0.59 0.00
(0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

97.3802066

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

130.93

457073.31

EPS(TTM)

Face Value()

Div & Yield %

14.55

0.84

Back

satchmo holdings ltd

Sun Pharmaceutical Industries consolidated net profit declines 36.22% in the September 2026 quarter

Oct 30,2026

Net profit of Sun Pharmaceutical Industries declined 36.22% to Rs 1988.53 crore in the quarter ended September 2026 as against Rs 3117.95 crore during the previous quarter ended September 2025. Sales rose 11.77% to Rs 16100.01 crore in the quarter ended September 2026 as against Rs 14405.22 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	16100.01	14405.22	12
OPM %	29.47	31.43	-
PBDT	5186.54	4897.11	6
PBT	4428.20	4167.61	6
NP	1988.53	3117.95	-36

81,830.68 724.03 ( 0.89%)

52,245.46 -165.29 (-0.32%)

7,531.52 -39.42 (-0.52%)

61,257.85 798.27 (1.32%)

10,782.38 -0.49 (0.00%)

93.78 -0.25 (-0.27%)

104.91 0.16 (0.15%)

125.72 0.20 (0.16%)

0.59 0.00 (0.02%)